title: [Detection by SPECT-CT scan with (99m)Tc-(V) DMSA of bone metastases in patient with medullary thyroid cancer].
abstract: Multiple endocrine neoplasia syndrome, type 2B (MEN 2B), is a rare entity characterized by the presence of medullary thyroid cancer in 100% of the cases. The phenotype of this syndrome consists in the presence of marfanoid features and mucocutaneous neuromas. We describe the case of a male patient with MEN 2B syndrome who was diagnosed with medullary thyroid cancer after lung metastases was found. We analyze the role of DMSA-V and the new hybrid SPECT-CT scan systems in the extension study and monitoring of medullary thyroid cancer.
authors: Servicio de Medicina Nuclear, Hospital Universitario Virgen Macarena, Sevilla, España.
authors: A
authors: A
authors: De Bonilla-Damiá
authors: C
authors: C
authors: Calvo-Morón
authors: P A
authors: PA
authors: De La Riva-Pérez
authors: R
authors: R
authors: Iglesias-Jerez
authors: M
authors: M
authors: Molina-Mora
authors: J
authors: J
authors: Castro-Montaño
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000008:administration & dosage; D018276:Carcinoma, Medullary / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008159:Lumbar Vertebrae / Q000000981:diagnostic imaging*; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D064847:Multimodal Imaging; D018814:Multiple Endocrine Neoplasia Type 2b / Q000000981:diagnostic imaging* / Q000235:genetics; D037981:Neck Dissection; D009536:Niacinamide / Q000031:analogs & derivatives; D015282:Octreotide / Q000008:administration & dosage; D010671:Phenylurea Compounds; D049268:Positron-Emission Tomography; D051096:Proto-Oncogene Proteins c-ret / Q000235:genetics; D011725:Pyridines / Q000008:administration & dosage; D019275:Radiopharmaceuticals; D000077157:Sorafenib; D013125:Spinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary*; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D013904:Thoracic Vertebrae / Q000000981:diagnostic imaging*; D013964:Thyroid Neoplasms / Q000473:pathology* / Q000601:surgery; D013965:Thyroidectomy; D014057:Tomography, X-Ray Computed; D055815:Young Adult
chemical_list: D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D019275:Radiopharmaceuticals; D009536:Niacinamide; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D000077157:Sorafenib; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D015282:Octreotide